Androgen suppression plus radiation for prostate cancer.
Millar
Jeremy
J
D000726:Androgen Antagonists / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D020266:Radiotherapy, Conformal
D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal